{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:56:02Z","timestamp":1768712162496,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.lfs.2018.08.018","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T12:02:25Z","timestamp":1533988945000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a\/NCX1 depletion in streptozotocin induced cardiomyopathy in C57\/BL6 mice"],"prefix":"10.1016","volume":"210","author":[{"given":"Sadia","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Sayeed","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.Quamrul.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd.","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yam Nath","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.08.018_bb0005","author":"International Diabetic Federation"},{"key":"10.1016\/j.lfs.2018.08.018_bb0010","first-page":"411","article-title":"Diabetic cardiomyopathy: from pathophysiology to treatment","volume":"55","author":"Trachanas","year":"2014","journal-title":"Hell. J. Cardiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/978-1-4614-5441-0_6","article-title":"Type 2 diabetes mellitus, pandemic in 21st century","volume":"771","author":"Ginter","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0020","first-page":"1","article-title":"Endothelial dysfunction in pre-diabetes, diabetes and diabetic cardiomyopathy: a review","volume":"5","author":"Ciccone","year":"2014","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.lfs.2018.08.018_bb0025","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almoros","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2018.08.018_bb0040","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1089\/ars.2014.6123","article-title":"Protective mechanisms of mitochondria and heart function in diabetes","volume":"22","author":"Aon","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2018.08.018_bb0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.lfs.2012.10.028","article-title":"Molecular and metabolic mechanisms of cardiac dysfunction in diabetes","volume":"92","author":"Mandavia","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.08.018_bb0050","doi-asserted-by":"crossref","first-page":"35049","DOI":"10.1074\/jbc.M304913200","article-title":"Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells","volume":"278","author":"Konishi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.08.018_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-230X(08)60784-8","article-title":"Biochemical and clinical implications of ErbB\/HER signaling network of growth factor receptors","volume":"77","author":"Klapper","year":"2000","journal-title":"Adv. Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2018.08.018_bb0060","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.celrep.2016.02.029","article-title":"Mutant KRas-induced mitochondrial oxidative stress in acinar cells upregulates EGFR signaling to drive formation of pancreatic precancerous lesions","volume":"14","author":"Geou-Yarh","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2018.08.018_bb0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijcard.2011.01.049","article-title":"And what about epidermal growth factor (EGF) as the bridge between survivin and cardiac remodelling?","volume":"148","author":"Mormile","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.112.197038","article-title":"The epidermal growth factor receptor: a missing link between endoplasmic reticulum stress and diabetic complication?","volume":"60","author":"Kobayashi","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.lfs.2018.08.018_bb0075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/jcmm.12763","article-title":"Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II","volume":"20","author":"Peng","year":"2016","journal-title":"J. Cell. Mol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2018.08.018_bb0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1634\/theoncologist.10-7-461","article-title":"FDA drug approval summary: erlotinib (Tarceva\u00ae) tablets","volume":"10","author":"Cohen","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.lfs.2018.08.018_bb0085","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2018.08.018_bb0095","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/j.lfs.2018.08.018_bb0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2007.12.012","article-title":"Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL\/6J mice","volume":"228","author":"Barrick","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.02.029","article-title":"EGFR inhibition protects the cardiac remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model","volume":"82","author":"Liang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1039\/an9729700142","article-title":"An improved color reagent for the determination of blood glucose by oxidase system","volume":"97","author":"Barham","year":"1972","journal-title":"Analyst"},{"key":"10.1016\/j.lfs.2018.08.018_bb0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurements with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.08.018_bb0120","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1074\/jbc.270.8.3479","article-title":"1\u2011Chloro\u20112,4\u2011dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity","volume":"24","author":"Arner","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.08.018_bb0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2018.08.018_bb0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of superoxide anion radical in auto-oxidation by pyrogallol and a convenient assay of superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.lfs.2018.08.018_bb0135","series-title":"Handbook of Methods for Oxygen Free Radical Research","first-page":"283","article-title":"Catalase activity","author":"Claiborne","year":"1985"},{"key":"10.1016\/j.lfs.2018.08.018_bb0140","series-title":"Effects of Drugs on Clinical Laboratory Tests","first-page":"120","author":"Young","year":"1990"},{"key":"10.1016\/j.lfs.2018.08.018_bb0145","first-page":"30","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"34","author":"Okhawa","year":"1970","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2018.08.018_bb0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcp\/61.1.108","article-title":"A comparison of serum versus heparinised plasma for routine chemistry tests","volume":"61","author":"Lum","year":"1974","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lfs.2016.03.049","article-title":"Levosimendan reduces myocardial damage and improves cardiodynamics in streptozotocin induced diabetic cardiomyopathy via SERCA2a\/NCX1 pathway","volume":"153","author":"Akhtar","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.08.018_bb0160","article-title":"Hematoxylin and eosin staining of tissue and cell sections","author":"Fischer","year":"2008","journal-title":"CSH Protoc."},{"key":"10.1016\/j.lfs.2018.08.018_bb0165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mex.2015.02.007","article-title":"Determination of collagen content within picrosirius red stained paraffin-embedded tissue sections using fluorescence microscopy","volume":"2","author":"Vogel","year":"2015","journal-title":"MethodsX"},{"key":"10.1016\/j.lfs.2018.08.018_bb0170","series-title":"Immunohistochemistry II","author":"Cuello","year":"1993"},{"key":"10.1016\/j.lfs.2018.08.018_bb0175","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/nprot.2007.304","article-title":"Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research","volume":"2","author":"Graham","year":"2007","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.lfs.2018.08.018_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.08.018_bb0185","doi-asserted-by":"crossref","first-page":"26G","DOI":"10.1016\/j.amjcard.2005.07.018","article-title":"Cardioprotection a new paradism in the management of acute heart failure syndromes","volume":"96","author":"Maytin","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2015.04.002","article-title":"Diabetic cardiomyopathy: role of epidermal growth factor receptor tyrosine kinase","volume":"84","author":"Xu","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2018.08.018_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/HYPERTENSIONAHA.112.192500","article-title":"A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus","volume":"60","author":"Galan","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.lfs.2018.08.018_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067813","article-title":"Activation of erbb2 and downstream signalling via rho kinases and erk1\/2 contributes to diabetes-induced vascular dysfunction","volume":"8","author":"Akhtar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.08.018_bb0205","doi-asserted-by":"crossref","first-page":"e39066","DOI":"10.1371\/journal.pone.0039066","article-title":"Activation of EGFR\/ERBB2 via pathways involving ERK1\/2, P38 MAPK, AKT and FOXO enhances recovery of diabetic hearts from ischemia-reperfusion injury","volume":"7","author":"Akhtar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.08.018_bb0210","first-page":"1","article-title":"Dihydromyricetin protects against diabetic cardiomyopathy in Streptozotocin induced diabetic mice","author":"Wu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2018.08.018_bb0215","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00204-010-0615-8","article-title":"In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity","volume":"85","author":"Vavrova","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0220","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/cdd.2009.107","article-title":"Apoptosis and glutathione: beyond an antioxidant","volume":"16","author":"Franco","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2018.08.018_bb0225","doi-asserted-by":"crossref","first-page":"33669","DOI":"10.1074\/jbc.M111.284612","article-title":"Reductase-2 is essential for keeping low levels of H2O2 emission from isolated heart mitochondria","volume":"286","author":"Stanley","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2018.08.018_bb0230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/10641963.2015.1047947","article-title":"Levosimendan suppresses oxidative injury, apoptotic signaling and mitochondrial degeneration in streptozotocin-induced diabetic cardiomyopathy","volume":"38","author":"Akhtar","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.lfs.2018.08.018_bb0235","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1530\/JME-16-0249","article-title":"Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy","volume":"58","author":"Ritchie","year":"2017","journal-title":"J. Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.lfs.2018.08.018_bb0240","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jdi.12250","article-title":"Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage","volume":"5","author":"Liu","year":"2014","journal-title":"J. Diabetes Investig."},{"issue":"6","key":"10.1016\/j.lfs.2018.08.018_bb0245","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.yjmcc.2010.02.011","article-title":"Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system","volume":"48","author":"Moens","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2018.08.018_bb0250","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.106.102160","article-title":"Chronic \u03b2-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia\/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress","volume":"318","author":"Hu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2018.08.018_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/157340208786241336","article-title":"Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction","volume":"4","author":"Chen","year":"2008","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.lfs.2018.08.018_bb0260","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1152\/ajpheart.00578.2001","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1)","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1681\/ASN.2011070645","article-title":"EGFR signaling promotes TGF beta-dependent renal fibrosis","volume":"23","author":"Chen","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2018.08.018_bb0270","doi-asserted-by":"crossref","first-page":"H1534","DOI":"10.1152\/ajpheart.2000.279.4.H1534","article-title":"Alterations in myocardial collagen content affect rat papillary muscle function","volume":"279","author":"Matsubara","year":"2000","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.lfs.2018.08.018_bb0275","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2337\/dc17-0509","article-title":"Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial","volume":"40","author":"Ohkuma","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lfs.2018.08.018_bb0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2007.12.114","article-title":"The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation","volume":"369","author":"Solaroa","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2018.08.018_bb0285","doi-asserted-by":"crossref","first-page":"24580","DOI":"10.1038\/srep24580","article-title":"EGFR inhibition blocks palmitic acid-induced inflammation in cardiomyocytes and prevents hyperlipidemia-induced cardiac injury in mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2018.08.018_bb0290","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yjmcc.2012.11.017","article-title":"Calcium flux balance in the heart","volume":"58","author":"Eisner","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2018.08.018_bb0295","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.embor.7400914","article-title":"Role of Na\/Ca exchange and the plasma membrane Ca2+-ATPase in cell function","volume":"8","author":"Noble","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.lfs.2018.08.018_bb0300","article-title":"An altered pattern of myocardial histopathological and molecular changes underlies the different characteristics of type-1 and type-2 diabetic cardiac dysfunction","volume":"12","author":"Radovits","year":"2015","journal-title":"J. Diabetes Res."},{"issue":"8","key":"10.1016\/j.lfs.2018.08.018_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518304648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518304648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:14:23Z","timestamp":1758399263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518304648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":61,"alternative-id":["S0024320518304648"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.08.018","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a\/NCX1 depletion in streptozotocin induced cardiomyopathy in C57\/BL6 mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}